Published on 3 Nov 2022 on Zacks via Yahoo Finance
DermTech, Inc. (DMTK) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to loss of $0.68 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 3.03%. A quarter ago, it was expected that this company would post a loss of $1.02 per share when it actually produced a loss of $0.99, delivering a surprise of 2.94%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.